Luca Andrea Lotta
0000-0002-2619-5956
52 papers found
Refreshing results…
Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case–control study
FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients:
Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpura
Smoking and the Risk of Mortality and Vascular and Respiratory Events in Patients Undergoing Major Surgery
Next-generation sequencing study finds an excess of rare, coding single-nucleotide variants of ADAMTS13 in patients with deep vein thrombosis
Raised haematocrit concentration and the risk of death and vascular complications after major surgery
Prevalence of Disease and Relationships between Laboratory Phenotype and Bleeding Severity in Platelet Primary Secretion Defects
The emerging concept of residual ADAMTS13 activity in ADAMTS13-deficient thrombotic thrombocytopenic purpura
Preoperative Hematocrit Concentration and the Risk of Stroke in Patients Undergoing Isolated Coronary-Artery Bypass Grafting
Drop of residual plasmatic activity of ADAMTS13 to undetectable levels during acute disease in a patient with adult-onset congenital thrombotic thrombocytopenic purpura
Association of a single nucleotide polymorphism of the NPR3 gene promoter with early onset ischemic stroke in an Italian cohort
Treatment of chronic hepatitis C with pegylated interferon‐α in a patient with recurrent autoimmune thrombotic thrombocytopenic purpura
ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura
Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura
Measurement of anti-ADAMTS13 neutralizing autoantibodies: A comparison between CBA and FRET assays
Case report: use of thienopyridines in a patient with acquired idiopathic thrombotic thrombocytopenic purpura
Identification of genetic risk variants for deep vein thrombosis by multiplexed next-generation sequencing of 186 hemostatic/pro-inflammatory genes
Prothrombin mutation conveying antithrombin resistance [7]
B and T lymphocytes in acquired Thrombotic Thrombocytopenic Purpura during disease remission
Platelet reactive conformation and multimeric pattern of von Willebrand factor in acquired thrombotic thrombocytopenic purpura during acute disease and remission
Missing publications? Search for publications with a matching author name.